Anita van Esch

1.6k citations

16 papers · 1.3k indexed · h-index 16

Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Pediatrics, Perinatology and Child Health top 5%
Molecular Biology
Immunology top 10%

Co-authors: Els Wagenaar Alfred H. Schinkel Evita van de Steeg Kathryn E. Kenworthy Carine J. Peutz‐Kootstra Hong Xiao Peter Heeringa J. Charles Jennette
Topics: Drug Transport and Resistance Mechanisms (14 papers)Pharmacological Effects and Toxicity Studies (7 papers)Acute Lymphoblastic Leukemia research (4 papers)
Cited by: Oncology Pharmacology Pediatrics, Perinatology and Child Health
Journals: Journal of Clinical Investigation Clinical Cancer Research Kidney International
Partner nations: Netherlands United Kingdom Türkiye

In The Last Decade

Anita van Esch

16 papers receiving 1.3k citations

Peers

Countries citing papers authored by Anita van Esch

Since Specialization

Citations

This map shows the geographic impact of Anita van Esch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita van Esch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita van Esch more than expected).

Fields of papers citing papers by Anita van Esch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita van Esch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita van Esch. The network helps show where Anita van Esch may publish in the future.

Co-authorship network of co-authors of Anita van Esch

This figure shows the co-authorship network connecting the top 25 collaborators of Anita van Esch. A scholar is included among the top collaborators of Anita van Esch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita van Esch. Anita van Esch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug–Drug Interactions in Vivo 2015 ·Molecular Pharmaceutics ·Selvi Durmuş,(unknown),Anita van Esch,Els Wagenaar,Olaf van Tellingen,Alfred H. Schinkel	30
2	Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699) 2014 ·Pharmaceutical Research ·Selvi Durmuş,Rolf W. Sparidans,Anita van Esch,Els Wagenaar,Jos H. Beijnen,Alfred H. Schinkel	85
3	Human OATP1B1, OATP1B3 and OATP1A2 can mediate thein vivouptake and clearance of docetaxel 2014 ·International Journal of Cancer ·Dilek Iusuf,Jeroen J. M. A. Hendrikx,Anita van Esch,Evita van de Steeg,Els Wagenaar,Hilde Rosing,Jos H. Beijnen,Alfred H. Schinkel	47
4	OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and Carboxylesterase Expression in Knockout and Humanized Transgenic Mice 2013 ·Molecular Cancer Therapeutics ·Dilek Iusuf,Marion Ludwig,Ahmed M.O. Elbatsh,Anita van Esch,Evita van de Steeg,Els Wagenaar,Martin van der Valk,Fan Lin,Olaf van Tellingen,Alfred H. Schinkel	35
5	Bcrp1;Mdr1a/b;Mrp2 Combination Knockout Mice: Altered Disposition of the Dietary Carcinogen PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine) and Its Genotoxic Metabolites 2013 ·Molecular Pharmacology ·Maria L.H. Vlaming,Sebastiaan F. Teunissen,Evita van de Steeg,Anita van Esch,Els Wagenaar,Luc Brunsveld,Tom F. A. de Greef,Hilde Rosing,Jan H.M. Schellens,Jos H. Beijnen,Alfred H. Schinkel	21
6	Murine Oatp1a/1b Uptake Transporters Control Rosuvastatin Systemic Exposure Without Affecting Its Apparent Liver Exposure 2013 ·Molecular Pharmacology ·Dilek Iusuf,Anita van Esch,(unknown),Maxine Taylor,Kathryn E. Kenworthy,Evita van de Steeg,Els Wagenaar,Alfred H. Schinkel	33
7	Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice 2012 ·Clinical Cancer Research ·Evita van de Steeg,Anita van Esch,Els Wagenaar,Kathryn E. Kenworthy,Alfred H. Schinkel	101
8	Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver 2012 ·Journal of Clinical Investigation ·Evita van de Steeg,Viktor Stránecký,Hana Hartmannová,Lenka Nosková,Martin Hřebı́ček,Els Wagenaar,Anita van Esch,Dirk R. de Waart,Ronald P.J. Oude Elferink,Kathryn E. Kenworthy,Eva Sticová,(unknown),A. S. Knisely,Stanislav Kmoch,M Jirsa,Alfred H. Schinkel	260
9	Organic Anion-Transporting Polypeptides 1a/1b Control the Hepatic Uptake of Pravastatin in Mice 2012 ·Molecular Pharmaceutics ·Dilek Iusuf,Rolf W. Sparidans,Anita van Esch,(unknown),Kathryn E. Kenworthy,Evita van de Steeg,Els Wagenaar,Jos H. Beijnen,Alfred H. Schinkel	24
10	Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate 2011 ·Drug Metabolism and Disposition ·Maria L.H. Vlaming,Anita van Esch,Evita van de Steeg,(unknown),Els Wagenaar,Olaf van Tellingen,Alfred H. Schinkel	50
11	High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel 2010 ·Clinical Cancer Research ·Evita van de Steeg,Anita van Esch,Els Wagenaar,Cornelia M.M. van der Kruijssen,Olaf van Tellingen,Kathryn E. Kenworthy,Alfred H. Schinkel	45
12	Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo 2009 ·Molecular Cancer Therapeutics ·Maria L.H. Vlaming,Anita van Esch,(unknown),Els Wagenaar,Koen van de Wetering,Olaf van Tellingen,Alfred H. Schinkel	54
13	Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo 2009 ·Clinical Cancer Research ·Maria L.H. Vlaming,(unknown),Anita van Esch,Els Wagenaar,Dirk R. de Waart,Koen van de Wetering,Cornelia M.M. van der Kruijssen,Ronald P.J. Oude Elferink,Olaf van Tellingen,Alfred H. Schinkel	72
14	Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate 2008 ·Clinical Cancer Research ·Maria L.H. Vlaming,(unknown),Anita van Esch,Els Wagenaar,Olaf van Tellingen,Dirk R. de Waart,Ronald P.J. Oude Elferink,Koen van de Wetering,Alfred H. Schinkel	48
15	Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice 2007 ·Kidney International ·Dennis Huugen,Anita van Esch,Hong Xiao,Carine J. Peutz‐Kootstra,W. A. Buurman,J. W. Cohen Tervaert,J. Charles Jennette,Peter Heeringa	199
16	Aggravation of Anti-Myeloperoxidase Antibody-Induced Glomerulonephritis by Bacterial Lipopolysaccharide 2005 ·American Journal Of Pathology ·Dennis Huugen,Hong Xiao,Anita van Esch,Ronald J. Falk,Carine J. Peutz‐Kootstra,Wim A. Buurman,Jan Willem Cohen Tervaert,J. Charles Jennette,Peter Heeringa	185

About Anita van Esch

Anita van Esch is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Oncology (693 citations), Pharmacology (206 citations) and Pediatrics, Perinatology and Child Health (367 citations). Anita van Esch has collaborated with scholars based in Netherlands, United Kingdom and Türkiye. Frequent co-authors include Els Wagenaar, Alfred H. Schinkel, Evita van de Steeg, Kathryn E. Kenworthy, Carine J. Peutz‐Kootstra, Hong Xiao, Peter Heeringa, J. Charles Jennette, Dennis Huugen and Olaf van Tellingen. Their work appears in journals such as Journal of Clinical Investigation, Clinical Cancer Research and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact